Brodilan
Brodilan Uses, Dosage, Side Effects, Food Interaction and all others data.
A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
Brodilan is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. Although approved for use in some countries, as of fall, 2006, clenbuterol is not an ingredient of any therapeutic drug approved by the U.S. Food and Drug Administration.
Trade Name | Brodilan |
Generic | Clenbuterol |
Clenbuterol Other Names | Clenbuterol, Clenbutérol, Clenbuterolum |
Type | |
Formula | C12H18Cl2N2O |
Weight | Average: 277.19 Monoisotopic: 276.079618622 |
Groups | Approved, Investigational, Vet approved |
Therapeutic Class | |
Manufacturer | |
Available Country | Venezuela |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Brodilan is a decongestant and bronchodilator used in a variety of respiratory conditions.
Used as a bronchodilator in the treatment of asthma patients.
Brodilan is also used to associated treatment for these conditions: Bronchitis, Chronic Lung Diseases, Chronic Obstructive Pulmonary Disease (COPD)
How Brodilan works
Brodilan is a Beta(2) agonist similar in some structural respects to salbutamol. Agonism of the beta(2) receptor stimulates adenylyl cyclase activity which ultimately leads to downstream effects of smooth muscle relaxation in the bronchioles.
Elimination Route
89-98% orally
Half Life
36-39 hours
Innovators Monograph
You find simplified version here Brodilan